Five new blood pressure drugs enter human testing
NCT ID NCT07373613
Summary
This study is testing five different doses of an experimental medication called BR1400 for people with high blood pressure. Researchers will enroll 330 participants to see which dose works best at lowering blood pressure over 8 weeks while monitoring for side effects. The study uses a double-blind design, meaning neither participants nor doctors know which dose each person receives.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hanyang University Hospital
Soeul, South Korea
Contact
Conditions
Explore the condition pages connected to this study.